SAN DIEGO, CA (January 4, 2023) – Element Biosciences, Inc.— the developer of an innovative DNA sequencing platform disrupting genomics — announced that Element CEO and Co-Founder Molly He will speak at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 3:30 p.m. Pacific Time (6:30 p.m. Eastern Time) at the Westin St. Francis hotel in San Francisco.
About Element Biosciences, Inc.
Element Biosciences is a multi-disciplinary life science company focused on developing disruptive DNA sequencing technology for research and diagnostic markets. Through innovating the fundamental elements of a sequencing system, Element empowers customers with affordable, high-quality data and an improved user experience, in turn accelerating scientific discoveries and broadening the use of genomic medicine. To learn more about Element, visit www.elementbiosciences.com.